XIONG Bin, DONG Zhong-yi. Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 228-231. DOI: 10.3969/j.issn.1671-5144.2015.04.011
|
Citation:
|
XIONG Bin, DONG Zhong-yi. Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 228-231. DOI: 10.3969/j.issn.1671-5144.2015.04.011
|
XIONG Bin, DONG Zhong-yi. Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 228-231. DOI: 10.3969/j.issn.1671-5144.2015.04.011
|
Citation:
|
XIONG Bin, DONG Zhong-yi. Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 228-231. DOI: 10.3969/j.issn.1671-5144.2015.04.011
|
DownLoad: